CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20,996 enrolled
Drug / intervention
Dietary sodium reductionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02092090
NCT02092090N/ACompleted
CompareCT.gov

A LARGE-SCALE CLUSTER RANDOMIZED TRIAL TO DETERMINE THE EFFECTS OF SODIUM REDUCTION ON STROKE: THE CHINA SALT SUBSTITUTE AND STROKE STUDY (SSaSS)

The George Institute·interventional·Posted Mar 19, 2014·Updated Apr 8, 2021

In Brief

A clinical study evaluating Dietary sodium reduction for Stroke. Completed, enrolled 20,996 participants across 5 sites.

Detailed Summary

The study is a large scale cluster randomised trial to evaluate the effects of sodium reduction based upon the use of salt substitute on the risk of stroke defined as the occurrence of stroke and stroke deaths. The corresponding null hypothesis that will be tested is that sodium reduction will have no effect upon stroke risk. The secondary objectives are to determine effects of sodium reduction on major vascular events and total mortality.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesChina
CollaboratorsPeking University, Northwestern University, Imperial College London, China Medical University, China, Changzhi Medical College, Centers for Disease Control and Prevention, China, Ningxia Medical University, Xi'an Jiaotong University

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 19, 2014
Enrollment StartJul 9, 2014
Primary CompletionSep 4, 2020
TodayJul 2, 2026
Enrollment to primary: 6.2 yearsPosted 12.3 years ago

Interventions

Dietary sodium reductionbehavioral

Ongoing dietary advice and a supply of a reduced-sodium added-potassium salt substitute